ATE412186T1 - Src kinase inhibitoren zur behandlung von alzheimer krankheit - Google Patents

Src kinase inhibitoren zur behandlung von alzheimer krankheit

Info

Publication number
ATE412186T1
ATE412186T1 AT03776874T AT03776874T ATE412186T1 AT E412186 T1 ATE412186 T1 AT E412186T1 AT 03776874 T AT03776874 T AT 03776874T AT 03776874 T AT03776874 T AT 03776874T AT E412186 T1 ATE412186 T1 AT E412186T1
Authority
AT
Austria
Prior art keywords
disease
compound
alzheimer
treatment
src
Prior art date
Application number
AT03776874T
Other languages
English (en)
Inventor
Luc Mercken
Nicola Zambrano
Tommaso Russo
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE412186T1 publication Critical patent/ATE412186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03776874T 2002-10-22 2003-10-06 Src kinase inhibitoren zur behandlung von alzheimer krankheit ATE412186T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20020292608 EP1413887A1 (de) 2002-10-22 2002-10-22 Src Kinase Inhibitoren zur Behandlung von Alzheimer Krankheit

Publications (1)

Publication Number Publication Date
ATE412186T1 true ATE412186T1 (de) 2008-11-15

Family

ID=32050112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776874T ATE412186T1 (de) 2002-10-22 2003-10-06 Src kinase inhibitoren zur behandlung von alzheimer krankheit

Country Status (9)

Country Link
US (1) US20040176313A1 (de)
EP (2) EP1413887A1 (de)
JP (1) JP2006503570A (de)
AT (1) ATE412186T1 (de)
AU (1) AU2003286144A1 (de)
DE (1) DE60324309D1 (de)
DK (1) DK1556703T3 (de)
ES (1) ES2314261T3 (de)
WO (1) WO2004038422A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
US8618063B2 (en) * 2008-04-09 2013-12-31 The Board Of Trustees Of The University Of Illinois Method for treating a synucleinopathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2395136A1 (en) * 1999-12-22 2001-06-28 The Scripps Research Institute Angiogenesis and vascular permeability modulators and inhibitors
JP4317310B2 (ja) * 2000-03-09 2009-08-19 三菱化学株式会社 神経細胞死抑制作用を有する薬剤及びそのスクリーニング方法
CA2429641A1 (en) * 2000-12-06 2002-06-13 Incyte Genomics, Inc. Kinases and phosphatases
JP2006514821A (ja) * 2002-06-25 2006-05-18 セローノ ジェネティクス インスティテュート ソシエテ アノニム 新規なｋｃｎｑポリペプチド、それらのモジュレータ及び精神障害の治療におけるそれらの使用
US7195884B2 (en) * 2002-07-19 2007-03-27 Promega Corp. Methods and kits for transferases

Also Published As

Publication number Publication date
EP1556703A2 (de) 2005-07-27
WO2004038422A3 (en) 2004-09-02
EP1413887A1 (de) 2004-04-28
AU2003286144A8 (en) 2004-05-13
JP2006503570A (ja) 2006-02-02
ES2314261T3 (es) 2009-03-16
AU2003286144A1 (en) 2004-05-13
EP1556703B1 (de) 2008-10-22
DE60324309D1 (de) 2008-12-04
WO2004038422A2 (en) 2004-05-06
US20040176313A1 (en) 2004-09-09
DK1556703T3 (da) 2009-02-23

Similar Documents

Publication Publication Date Title
ATE405564T1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
DE602005023763D1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
DE60325209D1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
ATE396731T1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
EP1485381B8 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ECSP088350A (es) Pirazolopirimidinas como inhibidores de protein quinasas
WO2004071447A3 (en) Substituted azole derivatives as therapeutic agents
ATE493401T1 (de) Als proteinkinaseinhibitoren geeignete diaminotriazolverbindungen
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
SI1546127T1 (sl) Novi pirimidinamidni derivati in njihova uporaba
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
CY1110666T1 (el) Πυραζολοπυριμιδινες καταλληλες για θεραπεια καρκινικων νοσων
WO2007075572A3 (en) Orally active purine-based inhibitors of heat shock protein 90
DE60106409D1 (de) 3-aminopyrazole als inhibitoren von cyclinabhängigen kinasen
ATE547104T1 (de) Zusammensetzung enthaltend einen lungensurfactant und sildenafil zur behandlung von lungenerkrankungen
WO2004016741A3 (en) Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
ATE412186T1 (de) Src kinase inhibitoren zur behandlung von alzheimer krankheit
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
ATE392213T1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
SE0202608D0 (sv) New sequences

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties